The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.
Phe-119 in the reverse transcriptase (RT) of mouse mammary tumour virus (MMTV) is homologous with Tyr-115 in HIV type 1 (HIV-1) RT and to Phe-155 in murine leukaemia virus (MLV) RT. By mutating these residues in HIV-1 and MLV RTs (which are strict DNA polymerases) the enzymes were shown to function also as RNA polymerases. Owing to the uniqueness of MMTV as a type B retrovirus, we have generated a Phe-119-Val mutant of MMTV RT to study the involvement of this residue in affecting the catalytic features of this RT. The data presented here show that the mutant MMTV RT can incorporate both deoxyribonucleosides and ribonucleosides while copying either RNA or DNA. In addition, this mutant RT shows resistance to nucleoside analogues and an enhanced fidelity of DNA synthesis; all relative to the wild-type enzyme. The Phe-119-Val mutant is also different from the wild-type enzyme in its preference for most template primers tested and in its ability to synthesize DNA under non-processive and processive conditions. Overall, it is likely that the aromatic side chain of Phe-119 is located at the dNTP-binding site of MMTV RT and thus might be part of a putative "steric gate" that prevents the incorporation of nucleoside triphosphates. Since the only three-dimensional structures of RTs published so far are those of HIV-1 and MLV, it is likely that MMTV RT folds quite similarly to these RTs.
Entin-Meer
Michal
M
Department of Cell Biology and Histology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Sevilya
Ziv
Z
Hizi
Amnon
A
D001665:Binding Sites; D004279:DNA, Viral / Q000096:biosynthesis*; D024882:Drug Resistance, Viral; D054303:HIV Reverse Transcriptase / Q000235:genetics / Q000378:metabolism; D007700:Kinetics; D008324:Mammary Tumor Virus, Mouse / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D009705:Nucleosides / Q000494:pharmacology; D010649:Phenylalanine; D017354:Point Mutation; D012367:RNA, Viral / Q000096:biosynthesis; D012194:RNA-Directed DNA Polymerase / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D016914:Ribonuclease H / Q000378:metabolism; D012263:Ribonucleosides / Q000378:metabolism; D012266:Ribose / Q000378:metabolism*; D014633:Valine
D004279:DNA, Viral; D009705:Nucleosides; D012367:RNA, Viral; D012263:Ribonucleosides; D010649:Phenylalanine; D012266:Ribose; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase; D016914:Ribonuclease H; D014633:Valine